Translation of Pur-α is targeted by cellular miRNAs to modulate the differentiation-dependent susceptibility of monocytes to HIV-1 infection

FASEB Journal

Volumn 26, Issue 11, 2012, Pages 4755-4764

  Shen, Chan Juan ^a   Jia, Yan Hui ^a,b   Tian, Ren Rong ^a   Ding, Ming ^c   Zhang, Chiyu ^a,b   Wang, Jian Hua ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b JIANGSU UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Host factor; MicroRNA

Indexed keywords

BINDING PROTEIN; MICRORNA; PURINE RICH ELEMENT BINDING PROTEIN ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; MICROARRAY ANALYSIS; MONOCYTE; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HIV-1; HUMANS; MICRORNAS; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84868266765     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-209023     Document Type: Article

References (43)

1. Zhu, T. (2000) HIV-1 genotypes in peripheral blood monocytes. J. Leukoc. Biol. 68, 338-344
2. Zhu, T. (2002) HIV-1 in peripheral blood monocytes: an underrated viral source. J. Antimicrob. Chemother. 50, 309-311
3. Zhu, T., Muthui, D., Holte, S., Nickle, D., Feng, F., Brodie, S., Hwangbo, Y., Mullins, J. I., and Corey, L. (2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716
4. Coleman, C. M., and Wu, L. (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6, 51
5. Crowe, S., Zhu, T., and Muller, W. A. (2003) The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74, 635-641
6. Sonza, S., Mutimer, H. P., Oelrichs, R., Jardine, D., Harvey, K., Dunne, A., Purcell, D. F., Birch, C., and Crowe, S. M. (2001) Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15, 17-22
7. Lambotte, O., Taoufik, Y., de Goer, M. G., Wallon, C., Goujard, C., and Delfraissy, J. F. (2000) Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23, 114-119
8. Mikovits, J. A., Lohrey, N. C., Schulof, R., Courtless, J., and Ruscetti, F. W. (1992) Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J. Clin. Invest. 90, 1486-1491
9. McElrath, M. J., Steinman, R. M., and Cohn, Z. A. (1991) Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J. Clin. Invest. 87, 27-30
10. Collini, P., Noursadeghi, M., Sabroe, I., Miller, R. F., and Dockrell, D. H. (2010) Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr. Mol. Med. 10, 727-740
11. Kedzierska, K., and Crowe, S. M. (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9, 1893-1903
12. Triques, K., and Stevenson, M. (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J. Virol. 78, 5523-5527
13. Dong, C., Kwas, C., and Wu, L. (2009) Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J. Virol. 83, 3518-3527
14. Bergamaschi, A., and Pancino, G. (2010) Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7, 31
15. Valentin, A., Von Gegerfelt, A., Matsuda, S., Nilsson, K., and Asjo, B. (1991) In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J. Acquir. Immune Defic. Syndr. 4, 751-759
16. Arfi, V., Riviere, L., Jarrosson-Wuilleme, L., Goujon, C., Rigal, D., Darlix, J. L., and Cimarelli, A. (2008) Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J. Virol. 82, 6557-6565
17. Sonza, S., Maerz, A., Deacon, N., Meanger, J., Mills, J., and Crowe, S. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70, 3863-3869
18. Neil, S., Martin, F., Ikeda, Y., and Collins, M. (2001) Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J. Virol. 75, 5448-5456
19. Le Douce, V., Herbein, G., Rohr, O., and Schwartz, C. (2010) Molecular mechanisms of HIV-1 persistence in the monocytemacrophage lineage. Retrovirology 7, 32
20. Sung, T. L., and Rice, A. P. (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 5, e1000263
21. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., Yatim, A., Emiliani, S., Schwartz, O., and Benkirane, M. (2011) SAMHD1 is the dendritic-And myeloidcell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657
22. St Gelais, C., and Wu, L. (2011) SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 8, 55
23. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., and Skowronski, J. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661
24. Leavy, O. (2011) Antiviral immunity: SAMHD1-stopping HIV in its tracks. Nat. Rev. Immunol. 11, 440
25. Berger, A., Sommer, A. F., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., Panitz, S., Reuter, A., Ramos, I., Jatiani, A., Mulder, L. C., Fernandez-Sesma, A., Rutsch, F., Simon, V., Konig, R., and Flory, E. (2011) SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 7, e1002425
26. Goff, S. P. (2008) Knockdown screens to knockout HIV-1. Cell 135, 417-420
27. Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D. J., and Espeseth, A. S. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504
28. Konig, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T., Chiang, C. Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., Seidel, S., Opaluch, A. M., Caldwell, J. S., Weitzman, M. D., Kuhen, K. L., Bandyopadhyay, S., Ideker, T., Orth, A. P., Miraglia, L. J., Bushman, F. D., Young, J. A., and Chanda, S. K. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60
29. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., and Elledge, S. J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926
30. Kok, K. H., Lei, T., and Jin, D. Y. (2009) siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology 6, 78
31. Naghavi, M. H., and Goff, S. P. (2007) Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 19, 402-407
32. Van den Bergh, R., Florence, E., Vlieghe, E., Boonefaes, T., Grooten, J., Houthuys, E., Tran, H. T., Gali, Y., De Baetselier, P., Vanham, G., and Raes, G. (2010) Transcriptome analysis of monocyte-HIV interactions. Retrovirology 7, 53
33. Jager, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., Hernandez, H., Jang, G. M., Roth, S. L., Akiva, E., Marlett, J., Stephens, M., D'Orso, I., Fernandes, J., Fahey, M., Mahon, C., O'Donoghue, A. J., Todorovic, A., Morris, J. H., Maltby, D. A., Alber, T., Cagney, G., Bushman, F. D., Young, J. A., Chanda, S. K., Sundquist, W. I., Kortemme, T., Hernandez, R. D., Craik, C. S., Burlingame, A., Sali, A., Frankel, A. D., and Krogan, N. J. (2012) Global landscape of HIV-human protein complexes. Nature 481, 365-370
34. Gallia, G. L., Johnson, E. M., and Khalili, K. (2000) Puralpha: a multifunctional single-stranded DNA-And RNA-binding protein. Nucleic Acids Res. 28, 3197-3205
35. Krachmarov, C. P., Chepenik, L. G., Barr-Vagell, S., Khalili, K., and Johnson, E. M. (1996) Activation of the JC virus Tatresponsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc. Natl. Acad. Sci. U. S. A. 93, 14112-14117
36. Gallia, G. L., Darbinian, N., Tretiakova, A., Ansari, S. A., Rappaport, J., Brady, J., Wortman, M. J., Johnson, E. M., and Khalili, K. (1999) Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc. Natl. Acad. Sci. U. S. A. 96, 11572-11577
37. Daniel, D. C., Wortman, M. J., Schiller, R. J., Liu, H., Gan, L., Mellen, J. S., Chang, C. F., Gallia, G. L., Rappaport, J., Khalili, K., and Johnson, E. M. (2001) Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. J. Gen. Virol. 82, 1543-1553
38. Wortman, M. J., Krachmarov, C. P., Kim, J. H., Gordon, R. G., Chepenik, L. G., Brady, J. N., Gallia, G. L., Khalili, K., and Johnson, E. M. (2000) Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding. J. Cell. Biochem. 77, 65-74
39. Wang, J. H., Janas, A. M., Olson, W. J., and Wu, L. (2007) Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J. Virol. 81, 8933-8943
40. Lin, X., Liang, D., He, Z., Deng, Q., Robertson, E. S., and Lan, K. (2011) miR-K12-7-5p encoded by Kaposi's sarcoma-Associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One 6, e16224
41. Ellery, P. J., Tippett, E., Chiu, Y. L., Paukovics, G., Cameron, P. U., Solomon, A., Lewin, S. R., Gorry, P. R., Jaworowski, A., Greene, W. C., Sonza, S., and Crowe, S. M. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178, 6581-6589
42. Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S., and Ho, W. Z. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674
43. Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G., and Zhang, H. (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13, 1241-1247